Correlation Between Sartorius Stedim and Genfit

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Genfit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Genfit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Genfit, you can compare the effects of market volatilities on Sartorius Stedim and Genfit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Genfit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Genfit.

Diversification Opportunities for Sartorius Stedim and Genfit

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sartorius and Genfit is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Genfit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genfit and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Genfit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genfit has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Genfit go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Genfit

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.68 times more return on investment than Genfit. However, Sartorius Stedim Biotech is 1.47 times less risky than Genfit. It trades about -0.02 of its potential returns per unit of risk. Genfit is currently generating about -0.38 per unit of risk. If you would invest  18,400  in Sartorius Stedim Biotech on August 31, 2024 and sell it today you would lose (290.00) from holding Sartorius Stedim Biotech or give up 1.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Genfit

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Genfit 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Genfit are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Genfit may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Sartorius Stedim and Genfit Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Genfit

The main advantage of trading using opposite Sartorius Stedim and Genfit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Genfit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genfit will offset losses from the drop in Genfit's long position.
The idea behind Sartorius Stedim Biotech and Genfit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges